Bioventus Inc. — Director's Dealing 2021

Feb 12, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Bioventus Inc. (BVS)
CIK: 0001665988
Period of Report: 2021-02-11

Reporting Person: Parker David J (Director, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	3255332	Indirect

Footnotes

F1: These securities are held of record by AMP-CF Holdings, LLC (the "Investor"). Ampersand CF Limited Partnership ("AMP-CF LP") and Ampersand 2020 Limited Partnership ("AMP-20 LP") are the sole members and Managers of the Investor. AMP-CF Management Company Limited Partnership ("AMP-CF MCLP") is the general partner of AMP-CF LP and AMP-20 Management Company Limited Partnership ("AMP-20 MCLP") is the general partner of AMP-20 LP. By virtue of such relationships, AMP-CF LP, AMP-CF MCLP, AMP-20 LP and AMP-20 MCLP may be deemed to have voting and investment power with respect to the securities held by the Investor and as a result may be deemed to have beneficial ownership over such securities. The Reporting Person owns an indirect interest in AMP-CF MCLP and AMP-20 MCLP.

F2: Each of AMP-CF LP; AMP-CF MCLP; AMP-20 LP; AMP-20 MCLP and the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.